Molina Healthcare (MOH)
(Delayed Data from NYSE)
$330.12 USD
+4.69 (1.44%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $329.99 -0.13 (-0.04%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$330.12 USD
+4.69 (1.44%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $329.99 -0.13 (-0.04%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth C Momentum C VGM
Zacks News
Here's What Makes Molina Healthcare (MOH) an Attractive Bet
by Zacks Equity Research
Favorable changes across the industry and inside the company poise Molina Healthcare (MOH) for strong growth.
Near-Term Outlook for Health Maintenance Organization Industry
by Zacks Equity Research
Retiring baby boomer population, new streams of revenues and consolidation paint a bright picture for the HMO industry.
5 Stocks to Watch Out For on Recent Broker Rating Upgrades
by Zacks Equity Research
Broker advice is sought by investors as they strive to build a portfolio for generating handsome returns.
Is Molina Healthcare (MOH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
DXC Technology (DXC) Q2 Earnings Top, Revenues Lag Estimates
by Zacks Equity Research
DXC Technology's (DXC) fiscal Q2 earnings hurt by delay in ramp-up of a few large digital contracts. However, strength in digital business remains a tailwind.
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Lockheed Martin and Boeing
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Lockheed Martin and Boeing
Centene (CNC) in Focus: Stock Moves 9.2% Higher
by Zacks Equity Research
Centene (CNC) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Midterm Elections Put These Health Insurers in Focus
by Sapna Bagaria
U.S. Health Insurers should gain from Medicaid Expansion that might be bought by Democratic control in the House of Representatives.
US Stocks Enjoy Highest Post-Midterm Gains Since 1982: 5 Picks
by Swarup Gupta
A large swathe of market watchers thinks that a gridlocked Congress will be beneficial for U.S. equity markets.
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Facebook and Twitter
by Zacks Equity Research
The Zacks Analyst Blog Highlights: HCA Healthcare, Molina Healthcare, Johnson & Johnson, Facebook and Twitter
5 Top Stocks to Make the Most of a Divided Congress
by Tirthankar Chakraborty
Gridlock in Washington bodes well for healthcare and defense stocks, which calls for investing in such a space for the time being.
Election Day 2018: Here Are the Winners & Losers
by Tirthankar Chakraborty
One of the most awaited midterm elections in American history is upon us. Let's thus look at the sectors most likely to be impacted by the election results.
Zacks.com highlights: Illumina, Molina Healthcare, Twitter, Vocera Communications and WNS Holdings
by Zacks Equity Research
Zacks.com highlights: Illumina, Molina Healthcare, Twitter, Vocera Communications and WNS Holdings
Hasbro, Best Buy, Hess, Molina Health and Tetra Tech highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Hasbro, Best Buy, Hess, Molina Health and Tetra Tech highlighted as Zacks Bull and Bear of the Day
Go Beyond Earnings Growth, Bet on Beat With 5 Stocks
by Sanghamitra Saha
These top-ranked stocks are likely to beat on bottom line in their next releases.
A Horror of a Month: Zacks November Market Strategy
by John Blank
On Nov.1st, the S&P 500 traded at 2711. Thirty days earlier, the S&P 500 traded at 2920. We lost 209 points, and went -7.1% lower.
Molina Healthcare's (MOH) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q3 earnings beat on the back of an effective performance management and a margin recovery plan.
Molina (MOH) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 64.85% and -0.01%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Healthcare Q3 Earnings to Watch on Oct 31: ANTM, MOH, ESRX
by Zacks Equity Research
Healthcare stocks should gain from increase in revenues, higher premiums and enrollment partly offset by increase in expenses.
Zacks.com highlights: Tilly's, Crocs, Cadence Design Systems and Molina Healthcare
by Zacks Equity Research
Zacks.com highlights: Tilly's, Crocs, Cadence Design Systems and Molina Healthcare
What's in the Offing for Aetna (AET) This Earnings Season?
by Zacks Equity Research
Aetna's (AET) third-quarter earnings to gain from higher revenues, partly offset by increase in expenses.
Can Healthy Top-Line Growth Aid Ribbon's (RBBN) Q3 Earnings?
by Zacks Equity Research
Ribbon (RBBN) is likely to report higher year-over-year revenues in the third quarter of 2018 owing to healthy organic and inorganic growth initiatives.
Molina Healthcare's (MOH) Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Molina Healthcare (MOH) is likely to perform well in the third quarter on the back of a solid Medicaid business and its operational excellence.
4 Impressive Liquid Stocks for Maximum Returns
by Zacks Equity Research
Here are four top-ranked liquid stocks that can help investors build a winning portfolio.
Will Expenses Hurt WellCare Health's (WCG) Q3 Earnings?
by Zacks Equity Research
WellCare Health's (WCG) Q3 bottom line might suffer due to escalating expenses.